ANI Pharmaceuticals Inc (ANIP)
65.00
-0.43
(-0.66%)
USD |
NASDAQ |
Apr 25, 11:31
ANI Pharmaceuticals Price to Book Value: 3.164 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 3.185 |
| April 23, 2024 | 3.22 |
| April 22, 2024 | 3.195 |
| April 19, 2024 | 3.188 |
| April 18, 2024 | 3.144 |
| April 17, 2024 | 3.188 |
| April 16, 2024 | 3.192 |
| April 15, 2024 | 3.228 |
| April 12, 2024 | 3.256 |
| April 11, 2024 | 3.316 |
| April 10, 2024 | 3.260 |
| April 09, 2024 | 3.264 |
| April 08, 2024 | 3.291 |
| April 05, 2024 | 3.294 |
| April 04, 2024 | 3.308 |
| April 03, 2024 | 3.274 |
| April 02, 2024 | 3.248 |
| April 01, 2024 | 3.304 |
| March 28, 2024 | 3.366 |
| March 27, 2024 | 3.393 |
| March 26, 2024 | 3.386 |
| March 25, 2024 | 3.388 |
| March 22, 2024 | 3.388 |
| March 21, 2024 | 3.375 |
| March 20, 2024 | 3.318 |
| Date | Value |
|---|---|
| March 19, 2024 | 3.304 |
| March 18, 2024 | 3.292 |
| March 15, 2024 | 3.213 |
| March 14, 2024 | 3.216 |
| March 13, 2024 | 3.224 |
| March 12, 2024 | 3.240 |
| March 11, 2024 | 3.220 |
| March 08, 2024 | 3.282 |
| March 07, 2024 | 3.248 |
| March 06, 2024 | 3.204 |
| March 05, 2024 | 3.181 |
| March 04, 2024 | 3.234 |
| March 01, 2024 | 3.270 |
| February 29, 2024 | 3.294 |
| February 28, 2024 | 2.935 |
| February 27, 2024 | 2.918 |
| February 26, 2024 | 2.933 |
| February 23, 2024 | 2.879 |
| February 22, 2024 | 2.831 |
| February 21, 2024 | 2.726 |
| February 20, 2024 | 2.761 |
| February 16, 2024 | 2.824 |
| February 15, 2024 | 2.722 |
| February 14, 2024 | 2.653 |
| February 13, 2024 | 2.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.239
Minimum
Jun 16 2022
4.965
Maximum
Jul 30 2019
2.575
Average
2.254
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 1.786 |
| ADMA Biologics Inc | 10.75 |
| Dentsply Sirona Inc | 1.912 |
| Allogene Therapeutics Inc | 0.9556 |
| Vanda Pharmaceuticals Inc | 0.4773 |
Price to Book Value Related Metrics
| PE Ratio | 79.27 |
| PS Ratio | 2.431 |
| Price to Free Cash Flow | 11.78 |
| Price | 65.00 |
| Earnings Yield | 1.26% |
| Market Cap | 1.369B |
| Operating PE Ratio | 23.89 |
| Normalized PE Ratio | 70.98 |